Bristol-Myers Squibb Company financial reports, Bristol-Myers Squibb Company annual revenue in 2024. When does Bristol-Myers Squibb Company report revenue?
Bristol-Myers Squibb Company total revenue, net income and dynamics of changes in Brazilian real today
Bristol-Myers Squibb Company current income and income for the latest reporting periods. Bristol-Myers Squibb Company net revenue for today is 11 703 000 000 R$. Net income, revenue and dynamics - the main financial indicators of Bristol-Myers Squibb Company. Bristol-Myers Squibb Company financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. All information on Bristol-Myers Squibb Company total revenue on this chart is created in the form of yellow bars. The value of all Bristol-Myers Squibb Company assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
59 904 146 100 R$
+86.56 % ↑
5 400 228 500 R$
-26.327 % ↓
31/03/2021
56 679 365 100 R$
+87.04 % ↑
10 344 892 700 R$
+18.19 % ↑
31/12/2020
56 653 771 600 R$
+39.31 % ↑
-51 325 204 900 R$
-
30/09/2020
53 951 098 000 R$
+75.46 % ↑
9 582 206 400 R$
+38.36 % ↑
31/12/2019
40 668 071 500 R$
-
-5 405 347 200 R$
-
30/09/2019
30 748 030 900 R$
-
6 925 601 100 R$
-
30/06/2019
32 109 605 100 R$
-
7 329 978 400 R$
-
31/03/2019
30 302 704 000 R$
-
8 752 977 000 R$
-
Show:
to
Bristol-Myers Squibb Company financial report charts
Dates of Bristol-Myers Squibb Company finance reports: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Bristol-Myers Squibb Company is 30/06/2021. Gross profit Bristol-Myers Squibb Company is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Bristol-Myers Squibb Company is 9 340 000 000 R$
Bristol-Myers Squibb Company quarterly report dates
Cost of revenue Bristol-Myers Squibb Company is the total cost of producing and distributing of products and services of a company. Cost of revenue Bristol-Myers Squibb Company is 2 363 000 000 R$ Total revenue Bristol-Myers Squibb Company refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Bristol-Myers Squibb Company is 11 703 000 000 R$ Operating income Bristol-Myers Squibb Company is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Bristol-Myers Squibb Company is 2 666 000 000 R$
Net income Bristol-Myers Squibb Company is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Bristol-Myers Squibb Company is 1 055 000 000 R$ Current assets Bristol-Myers Squibb Company is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Bristol-Myers Squibb Company is 29 161 000 000 R$ Total assets Bristol-Myers Squibb Company refers to the total amount of assets owned by a person or entity. Total assets Bristol-Myers Squibb Company is 110 797 000 000 R$
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
47 808 658 000 R$
44 271 636 300 R$
45 213 477 100 R$
43 493 593 900 R$
31 725 702 600 R$
21 595 795 300 R$
22 624 654 000 R$
20 925 245 600 R$
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
12 095 488 100 R$
12 407 728 800 R$
11 440 294 500 R$
10 457 504 100 R$
8 942 368 900 R$
9 152 235 600 R$
9 484 951 100 R$
9 377 458 400 R$
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
59 904 146 100 R$
56 679 365 100 R$
56 653 771 600 R$
53 951 098 000 R$
40 668 071 500 R$
30 748 030 900 R$
32 109 605 100 R$
30 302 704 000 R$
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
13 646 454 200 R$
11 486 362 800 R$
6 388 137 600 R$
10 437 029 300 R$
7 104 755 600 R$
9 264 847 000 R$
10 636 658 600 R$
9 152 235 600 R$
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
5 400 228 500 R$
10 344 892 700 R$
-51 325 204 900 R$
9 582 206 400 R$
-5 405 347 200 R$
6 925 601 100 R$
7 329 978 400 R$
8 752 977 000 R$
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
11 573 380 700 R$
11 389 107 500 R$
13 201 127 300 R$
11 634 805 100 R$
9 955 871 500 R$
6 971 669 400 R$
6 572 410 800 R$
6 654 310 000 R$
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
46 257 691 900 R$
45 193 002 300 R$
50 265 634 000 R$
43 514 068 700 R$
33 563 315 900 R$
21 483 183 900 R$
21 472 946 500 R$
21 150 468 400 R$
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
149 266 410 700 R$
138 773 075 700 R$
154 543 790 400 R$
175 453 679 900 R$
150 254 319 800 R$
205 725 671 700 R$
193 056 889 200 R$
87 493 939 100 R$
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
567 136 603 900 R$
575 521 034 500 R$
606 468 694 700 R$
642 581 123 200 R$
665 144 352 800 R$
293 982 297 100 R$
282 362 848 100 R$
178 304 795 800 R$
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
56 428 548 800 R$
56 213 563 400 R$
74 456 610 200 R$
99 481 934 500 R$
63 195 470 200 R$
156 064 044 300 R$
145 391 554 800 R$
37 545 664 500 R$
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
93 692 684 800 R$
53 690 044 300 R$
49 707 695 700 R$
45 254 426 700 R$
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
400 517 800 200 R$
203 104 897 300 R$
199 690 724 400 R$
99 901 667 900 R$
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
60.22 %
69.09 %
70.72 %
56.03 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
188 409 109 600 R$
192 488 713 500 R$
193 599 471 400 R$
256 743 754 600 R$
264 114 682 600 R$
90 334 817 600 R$
82 150 016 300 R$
77 896 376 600 R$
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
10 431 910 600 R$
13 083 397 200 R$
10 662 252 100 R$
7 114 993 000 R$
Last revenue report of Bristol-Myers Squibb Company was 30/06/2021. According to last financial report total revenue in Bristol-Myers Squibb Company was 59 904 146 100 Brazilian real and changed by +86.56% since last year. Net income in Bristol-Myers Squibb Company was 5 400 228 500 R$ in last quartal, net income changes to -26.327%.
Current cash Bristol-Myers Squibb Company - the sum of all of the cash a company has on the date of report. Current cash Bristol-Myers Squibb Company is 11 024 000 000 R$
Bristol-Myers Squibb Company stocks data
BMYB34.SA stock price
Bristol-Myers Squibb Company stock price today, BMYB34.SA stock quote.
